EPRX: Eupraxia Pharmaceuticals Sotuvga nisbatan narx

Eupraxia Pharma (EPRX) kompaniyasining korporativ logotipi

Eupraxia Pharmaceuticals (EPRX) kompaniyasining istiqbollari DiffuX orqali uzoq muddatli ta'sirga ega dori vositalari ekotizimini yaratishga asoslangan bo'lib, bu tarixiy P/S dinamikasi bilan qo'llab-quvvatlanadi, bunda joriy daraja taxminan 0.00 ni tashkil etadi. Kompaniyaning daromadlari osteoartrit terapiyalarini bozorga olib chiqishga bog'liq. Inyeksiyali dori vositalari uchun ishlab chiqarish sikllari sertifikatlangan CMO imkoniyatlari bilan ta'minlanadi, ular hozirda yangi sinovlarni amalga oshirish uchun kengaytirilmoqda.

Narxning daromadga nisbati: eupraxiapharma.com (EPRX) 06.04.2024 - 06.04.2024 uchun

eupraxiapharma.com (EPRX) kompaniyasining tahliliy kesimlari

Kompaniyaning jamlanma tahliliyoti:Eupraxia Pharma (EPRX)
Eupraxia Pharmaceuticals tayyor mahsulotlari

Eupraxia Pharmaceuticals kompaniyasining optimallashtirilgan logistikaga ega innovatsion dori yetkazib berish tizimlarini ishlab chiqishi P/S koeffitsientini biznesning bozor qiymatini monitoring qilish uchun asosiy vositaga aylantiradi. Ushbu ko'rsatkich joriy bozor kapitalizatsiyasini yillik daromad bilan solishtiradi, bu esa investorlarga aktivning haddan tashqari qiziganlik darajasini aniqlash va noyob dori yetkazib berish texnologiyalarini monetizatsiya qilish samaradorligini bozor kutgan kutganliklariga nisbatan baholash imkonini beradi.

Raqobatdosh kompaniyalar

HLN (Haleon) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Kenvue Inc KVUE|Verona Pharma Corp - Narxning daromadga nisbati|MENS: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Ligand Pharmaceuticals LGND|Amneal Pharmaceuticals Inc (AMRX) - Narxning daromadga nisbati|Perrigo Company PLC - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati alvotech.com|P/S multiplikatori Liquidia Technologies|Narxning daromadga nisbati Galapagos Genomics (GLPG)|ANIP: Narxning sotuvga nisbati|P/S multiplikatori MNKD (MannKind Corp)|Narx/daromad koeffitsiyenti Amphastar (AMPH)|PCRX: Kapitalizatsiyaning daromadga nisbati|SPRY - P/S multiplikatori|Theravance Biopharma, Inc. (TBPH) - Narxning daromadga nisbati|AQST (Aquestive Therapeutics) - Narxning daromadga nisbati|SCPH (scpharmaceuticals.com) - P/S multiplikatori|TECX: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Bozor kapitallashuvining daromadga nisbati|BioHarvest Sciences - Kapitalizatsiyaning daromadga nisbati|EXOZ: Kapitalizatsiya va daromad nisbati|ORMP - Narxning daromadga nisbati|ENTX: Narxning daromadga nisbati|HYFT: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati ABVC BioPharma Inc|CPIX (Cumberland Corp) - P/S multiplikatori|P/S multiplikatori quantumbiopharma.com|P/S multiplikatori FGEN|Kapitalizatsiyaning daromadga nisbati Telomir Pharmaceuticals, Inc. TELO|P/S multiplikatori RANI (Rani Therapeutics)|SNYR (Synergy CHC Corp) - Narxning sotuvga nisbati|RLYB: Kapitalizatsiyaning daromadga nisbati|lexariabioscience.com (LEXX) - Kapitalizatsiyaning daromadga nisbati|Pulmatrix Inc (PULM) - Narxning daromadga nisbati|PTHL: Kapitalizatsiyaning sotish hajmiga nisbati|APM (Aptorum Group Ltd) - P/S multiplikatori|Lyra Therapeutics Inc (LYRA) - Narx/daromad koeffitsiyenti|P/S multiplikatori IBO|Kapitalizatsiyaning sotish hajmiga nisbati TNFA|cbdMD, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PRFX|Altamira Therapeutics Ltd. - P/S multiplikatori|LIPO: Narxning daromadga nisbati|OPTN: P/S multiplikatori|Narxning sotuvga nisbati PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - P/S multiplikatori|PTPI (Petros Pharmaceuticals Inc) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori QLI|SLRN - Sotuvga nisbatan narx|P/S multiplikatori TFFP (TFF Pharmaceuticals, Inc)